These novel medications , Retatrutide, represent a significant advancement in treating type 2 diabetes and possibly associated disorders. These drugs are classified as GLP-1 receptor stimulators, https://gretahmjw443569.blog-gold.com/58905898/semaglutide-a-deep-dive-into-incretin-compounds